Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Brahmi (Bacopa monnieri) has a longstanding tradition in Ayurvedic medicine for supporting cognitive health and mental clarity, but there is also a growing body of scientific research investigating its effects on neurotransmitters and related body systems. Preclinical studies have demonstrated that Brahmi influences key neurotransmitters such as serotonin, dopamine, and acetylcholine. These effects are believed to underlie its reputed benefits for memory, learning, and mood.

Several randomized controlled trials in humans have found that standardized extracts of Bacopa monnieri improve certain measures of cognitive function, particularly memory acquisition and retention, in healthy adults. The mechanism appears to involve modulation of cholinergic systems, antioxidant activity, and perhaps mild inhibition of acetylcholinesterase, leading to increased acetylcholine levels in the brain. Some animal studies also suggest Brahmi impacts serotonin and dopamine pathways, which could explain observed anxiolytic and antidepressant-like effects.

However, while the evidence is promising, it is not yet comprehensive or conclusive. Most clinical trials are of relatively short duration and use varying extracts, making direct comparisons and firm conclusions difficult. The overall evidence supports a modest but consistent positive effect on neurotransmitter-related functions, justifying a rating of 3 out of 5 for scientific support.

More about Brahmi
More about Specific Neurotransmitters

Other ingredients that support Specific Neurotransmitters

Other body systems supported by Brahmi

Products containing Brahmi